Form 144 | Pharvaris(PHVS.US) Officer Proposes to Sell 417.4K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 23, $Pharvaris(PHVS.US)$ Officer MORGAN CONN intends to sell 20,000 shares of its common stock on Apr 23, with a total market value of approximately $417.4K. MORGAN CONN
moomoo NewsApr 23 16:23 ET
Express News | Morgan Stanley Maintains Overweight on Pharvaris, Maintains $34 Price Target
Moomoo 24/7Apr 22 13:28 ET
Form 144 | Pharvaris(PHVS.US) Officer Proposes to Sell 311.9K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 15, $Pharvaris(PHVS.US)$ Officer MORGAN CONN intends to sell 14,242 shares of its common stock on Apr 15, with a total market value of approximately $311.9K. Source: Ann
moomoo NewsApr 15 16:38 ET
Pharvaris Is Maintained at Overweight by Morgan Stanley
Pharvaris Is Maintained at Overweight by Morgan Stanley
Dow JonesApr 15 12:56 ET
Express News | Morgan Stanley Maintains Overweight on Pharvaris, Lowers Price Target to $34
Moomoo 24/7Apr 15 12:45 ET
Express News | Pharvaris Shares Are Trading Lower After the Company Filed for a Mixed Shelf Offering
Moomoo 24/7Apr 15 10:34 ET
Pharvaris Earns Buy Rating as Deucrictibant Shows Promising Progress in HAE Treatment
TipRanksApr 14 21:25 ET
Pharvaris Files for Automatic Mixed Securities Shelf
Seeking AlphaApr 12 16:34 ET
Express News | Pharvaris NV Files for Mixed Shelf Offering; Size Not Disclosed- SEC Filing
Moomoo 24/7Apr 12 16:19 ET
Pharvaris N.V.'s High-Stakes Gamble: Navigating Clinical Trials and Regulatory Hurdles for Market Success
TipRanksApr 12 02:00 ET
Buy Rating Affirmed for Pharvaris on Strong HAE Drug Potential and Solid Financials
TipRanksApr 12 01:39 ET
Pharvaris Price Target Raised to $50.00/Share From $49.00 by JMP Securities
Pharvaris Price Target Raised to $50.00/Share From $49.00 by JMP Securities
Dow JonesApr 11 12:23 ET
Wedbush Reaffirms Their Buy Rating on Pharvaris (PHVS)
TipRanksApr 11 08:15 ET
Pharvaris Excels in HAE Treatment Advances
TipRanksApr 11 04:40 ET
Buy Rating Affirmed for Pharvaris on Strong Clinical Progress and Financial Stability
TipRanksApr 11 00:25 ET
Pharvaris Narrows Q4 Net Loss; Hires New CFO
Pharvaris (PHVS) late Wednesday reported a Q4 net loss of 0.74 euros ($0.80) per diluted share, compared with a 1.16 euro loss a year earlier. Analysts polled by Capital IQ expected a 0.57 loss. As ex
MT NewswiresApr 10 17:35 ET
Express News | Pharvaris Q4 EPS $(0.80) Misses $(0.58) Estimate
Moomoo 24/7Apr 10 17:32 ET
Pharvaris N.V. EPS €(0.74) Vs €(1.16) YoY; Cash And Cash Equivalents Were ~€391 Million As Of December 31, 2023
Fourth Quarter and Full Year 2023 Financial ResultsLiquidity Position. Cash and cash equivalents were approximately €391 million as of December 31, 2023, compared to approximately €162 million for Dec
BenzingaApr 10 16:14 ET
Pharvaris 4Q Loss/Shr EUR0.74 >PHVS
Pharvaris 4Q Loss/Shr EUR0.74 >PHVS
Dow JonesApr 10 16:11 ET
Express News | Pharvaris Appoints David Nassif As Chief Financial Officer
Moomoo 24/7Apr 10 16:10 ET
No Data
No Data